Cargando...
Cost-Effectiveness of Novel First-Line Therapeutic Regimens for Tuberculosis
OBJECTIVE: To evaluate the cost-effectiveness of novel first-line treatment regimens for tuberculosis (TB). DESIGN: Using decision analysis, we projected costs and effectiveness, from the healthcare perspective, of treating a patient cohort in the public sector for active TB without known or suspect...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3844288/ https://ncbi.nlm.nih.gov/pubmed/23575322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.12.0776 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|